John is an international health care leader in measurement, health policy, health systems, and quality of clinical care. He has contributed to more than 200 peer-reviewed publications and several books on quality, measurement, economics and healthcare systems. An actively funded National Institutes of Health (NIH) researcher, John works with clinical leaders, academic medical centers and multidisciplinary teams to help healthcare organizations better align their clinical staff. For almost two decades, he has examined how health systems affect, and potentially improve, care quality and patient outcomes. His leadership in this arena has led to his placement on Institute of Medicine and NIH committees and World Health Organization task forces. He has also testified before Congress on these issues. John developed the globally adopted standard for measuring clinical practice variation, known now simply as CPV Vignettes, the pillar stone of QURE Healthcare.
Read more about John Peabody
Dr. Burgon is a nationally recognized leader in healthcare strategy and has worked extensively with senior health system leaders across the country on projects ranging from demand forecasting and value-based payment structures to clinical technology assessment and cancer center development. In addition, Trever speaks frequently at national conferences on issues on of quality and value in healthcare. Before joining QURE, Trever served as Vice President at Sg2 (now a division of MedAssets), a health care analytics and intelligence company. At Sg2, Trever led the firm’s Center for Clinical Technology as well as the Oncology Strategy team. Trever holds a PhD from Stanford University in Microbiology and Immunology and received his BS from Brigham Young University.
Vice President of Strategy and Solutions
As Vice President of Strategy and Solutions, Scott brings a deep background in healthcare quality performance improvement and a proven track record of rapidly growing market penetration for numerous healthcare innovations. In addition to his clinical experience as an infectious diseases pharmacist, for more than a decade Scott has helped health systems, life science companies, and outcomes research efforts provide safer, better and more cost-effective healthcare.
As QURE Healthcare continues to expand, Dr. Pope leads the go-to-market strategies and sales initiatives for QURE’s unique Clinical Performance and Value (CPV®) vignettes.
Scott earned his PharmD degree and a minor in business administration from Ohio Northern University. He completed a general practice residency at Moses Cone Memorial Hospital and specialty residency in infectious diseases/internal medicine/academic through Campbell University at Duke University Medical Center.
He is a proud husband and father of two strong willed daughters.
Chief Medical Officer
Dr. Diana Tamondong-Lachica is the Physician Lead of QURE Healthcare, Inc. She is a practicing general internist, an educator, and an advocate. She obtained her medical degree from the University of the Philippines College of Medicine in 2007, finishing as the Class Valedictorian and in the same year, she placed 3rd in the Physician Licensure Exam. She did her residency training and chief residency for Internal Medicine in the Philippine General Hospital, the premiere health care training institution in the Philippines. She is a lecturer in UP College of Medicine, Ateneo School of Medicine and Public Health and the San Beda College of Medicine. She is an advocate and teacher of evidence-based medicine and has done consultancy work for health policy and implementation as well.
Jeremy contributes to QURE’s clinical case developing and content creation. His areas of clinical expertise include obstetrics and gynecology and minimally invasive surgery.
He is a graduate of the Yale University School of Medicine and received his undergraduate degree from Harvard. He performed his residency at Columbia-Presbyterian Medical Center in New York City and served as Chief Resident from 1999-2000. Dr. Miller enjoys providing general gynecologic care and obstetrical care. He is also a skilled surgeon with an interest in minimally invasive surgical procedures including hysteroscopy, endometrial ablation, and laparoscopic hysterectomy.
Othman has previous experience working in consulting policy analysis, project implementation support and other strategic business services to healthcare provider and information technology organizations. His services primarily focus on healthcare reform, health policy and health information technology.
Othman served as a research assistant while attending Stanford University, where he engaged in the analysis and compilation of data on U.S. medical start-up acquisitions. He also served worked with The Public Health Institute where he worked with health systems to plan and implement their community benefit programs, as well as completed a healthcare policy fellowship with The Bell Policy Center.
Director of Analytics and Research
As Director of Analytics and Research at QURE Healthcare, David is responsible for planning and executing data analyses related to QURE’s core business, as well as guiding and overseeing the overall analytics and statistical modeling projects of the analytics team. David received his Master of Public Health from Dartmouth College in 2003, with an emphasis in quality improvement and biostatistics, and a Bachelor of Science in Electrical Engineering from the University of California, Irvine. David has over ten years of experience related to healthcare analysis and outcomes, and he has been a contributing author to over a dozen peer-reviewed articles. Prior to this, he worked in semiconductor technology at IBM, where he fulfilled several technical and information technology roles for US and international clients to enable the success of a multiple projects.
Business and Research Analyst
Director of Clinical Programs
As Director of Clinical Programs, Mary oversees study development and quality assurance across each of QURE’s program pillars: health care providers, life sciences and global health. Mary brings experience as a health strategist and management consultant, with significant market access, pricing, and reimbursement experience, advising both health care providers and life sciences companies. In previous roles, she also tracked emerging trends impacting oncology service line management in the US as well as market access and marketing in Latin America, Europe and Asia.